Overview
- The transaction includes patient service centers and in‑office phlebotomy sites tied to CHS-affiliated hospitals across 13 states.
- CHS will retain and operate inpatient and emergency department laboratories, including testing that supports imaging and pre-admission services.
- CHS President and interim CEO Kevin Hammons said the move sharpens focus on core services, while Labcorp executive Mark Schroeder emphasized expanded access to innovative testing.
- Labcorp framed the acquisition as part of a broader strategy to partner with health systems to increase access, improve quality and drive operational efficiencies.
- The deal adds to a consolidation trend that includes University Hospitals’ sale to Quest, Labcorp’s purchases from North Mississippi Health Services and Ballad Health, and a Parkview Health agreement expected to close in 2026.